Our Team

Home
About
Nov­el Can­cer Ther­a­py
Intra­cel­lu­lar Drug Deliv­ery
News
Bib­li­og­ra­phy
Con­tact

Board of Directors

Jozef Zienkiewicz, Ph.D.
CEO, Principal Scientist

Jozef Zienkiewicz, Ph.D., is a for­mer Research Pro­fes­sor at Van­der­bilt Uni­ver­si­ty School of Med­i­cine with over 20 years of expe­ri­ence devel­op­ing and val­i­dat­ing bio­log­ic ther­a­pies. Trained in Bio­log­ic, Organ­ic, and Phys­i­cal Chem­istry, his exper­tise spans immunol­o­gy, chem­i­cal biol­o­gy, and chem­istry of pro­teins and pep­tides. His stud­ies on cell pen­e­trat­ing pep­tides and sig­nal­ing to the cel­l’s nucle­us led to the inven­tion of KaMoZo’s two core tech­nolo­gies.

John Wesley Wilson, Esq.
President, General Counsel

Wes­ley is a Colum­bia Law School grad­u­ate, where he was a James Kent Schol­ar. He earned a BA in Phi­los­o­phy, Pol­i­tics, and Eco­nom­ics from the Uni­ver­si­ty of Oxford (Mer­ton Col­lege). He pre­vi­ous­ly prac­ticed cor­po­rate law at Skad­den, Arps, Slate, Meagher & Flom and is admit­ted to prac­tice in New York. At KaMo­Zo, he works on busi­ness devel­op­ment and over­sees legal and gov­er­nance mat­ters.

Krzysztof K. Zienkiewicz, M.S.
Director

Krzysztof is a Van­der­bilt Uni­ver­si­ty alum­nus hold­ing dou­ble major BS degree in Com­put­er Sci­ence and Math­e­mat­ics and a MS degree in Com­put­er Sci­ence from the School of Engi­neer­ing. He has a very pro­duc­tive career as a soft­ware devel­op­er spe­cial­iz­ing in high-per­for­mance dis­trib­uted sys­tems. His exper­tise in cloud com­put­ing con­tributed sig­nif­i­cant­ly to KaMoZo’s accel­er­at­ed debut.

Home Page